The ‘Life Sciences Industrial Strategy: Who’s driving the bus?’ report has been published by the House of Lords Science and Technology Committee, recommending that the government should simplify its implementation arrangements.
To mark World Malaria Day, the founder of specialist smartphone diagnostics company Novarum DX and BBI Group head of mobile, Dr Neil Polwart, has spoken out to highlight the importance of new diagnostic technologies in tackling the spread of malaria
In this online exclusive, anti-malarial specialist, TravelPharm, and digital agency, Fifteen, reveal their research findings, which show that more work is needed in communicating malarial risks to travellers…
A new poll from YouGov has revealed that the majority of the British public will personally step up to help the NHS advance medical research and fight diseases of the future.
A new study from the University of Eastern Finland, published in the European Journal of Clinical Pharmacology, has highlighted that there are differences in the availability of orphan medicines between different European countries.
In this online exclusive, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), looks at the importance of vaccines in the fight against antimicrobial resistance (AMR).
According to a new report from the manufacturers’ organisation, EEF, and AIG has revealed that nearly half of manufacturers have been the victim of cyber-crime with a quarter suffering some financial loss or disruption to business as a result.
Commonly overlooked or the first item to be axed when budgets get cut, vacuum conveying is often considered a necessary evil in processing. Yet, as Andrew Turner, Hanningfield Process Systems reveals if well-designed it can be a process champion
To address the growing gap between how healthcare professionals want to receive information & what can be provided, the world’s largest pharma companies have collaborated to simplify digital engagement. Jan van den Burg, Veeva Systems, tells us more
Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development.
In this article, Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon, Arthur D. Little, introduce a framework to guide analogue-native companies in the use of levers to manage the transition to digital.
